231 related articles for article (PubMed ID: 24493389)
1. Role of routine imaging in detecting recurrent lymphoma: A review of 258 patients with relapsed aggressive non-Hodgkin and Hodgkin lymphoma.
El-Galaly TC; Mylam KJ; Bøgsted M; Brown P; Rossing M; Gang AO; Haglund A; Arboe B; Clausen MR; Jensen P; Pedersen M; Bukh A; Jensen BA; Poulsen CB; d'Amore F; Hutchings M
Am J Hematol; 2014 Jun; 89(6):575-80. PubMed ID: 24493389
[TBL] [Abstract][Full Text] [Related]
2. Limited utility of surveillance imaging for detecting disease relapse in patients with non-Hodgkin lymphoma in first complete remission.
Truong Q; Shah N; Knestrick M; Curley B; Hu Y; Craig M; Hamadani M
Clin Lymphoma Myeloma Leuk; 2014 Feb; 14(1):50-5. PubMed ID: 24119465
[TBL] [Abstract][Full Text] [Related]
3. Advanced-stage Hodgkin lymphoma: US/chest radiography for detection of relapse in patients in first complete remission--a randomized trial of routine surveillance imaging procedures.
Picardi M; Pugliese N; Cirillo M; Zeppa P; Cozzolino I; Ciancia G; Pettinato G; Salvatore C; Quintarelli C; Pane F
Radiology; 2014 Jul; 272(1):262-74. PubMed ID: 24708193
[TBL] [Abstract][Full Text] [Related]
4. The role of routine imaging procedures in the detection of relapse of patients with Hodgkin lymphoma and aggressive non-Hodgkin lymphoma.
Goldschmidt N; Or O; Klein M; Savitsky B; Paltiel O
Ann Hematol; 2011 Feb; 90(2):165-71. PubMed ID: 20706721
[TBL] [Abstract][Full Text] [Related]
5. Utility of post-therapy brain surveillance imaging in the detection of primary central nervous system lymphoma relapse.
Fossard G; Ferlay C; Nicolas-Virelizier E; Rey P; Ducray F; Jouanneau E; Faurie P; Belhabri A; Sunyack MP; Chassagne-Clément C; Thiesse P; Sebban C; Biron P; Blay JY; Ghesquières H
Eur J Cancer; 2017 Feb; 72():12-19. PubMed ID: 28012348
[TBL] [Abstract][Full Text] [Related]
6. Next-generation surveillance strategies for patients with lymphoma.
Cohen JB; Kurtz DM; Staton AD; Flowers CR
Future Oncol; 2015; 11(13):1977-91. PubMed ID: 26161931
[TBL] [Abstract][Full Text] [Related]
7. Limited utility of routine surveillance imaging for classical Hodgkin lymphoma patients in first complete remission.
Pingali SR; Jewell SW; Havlat L; Bast MA; Thompson JR; Eastwood DC; Bartlett NL; Armitage JO; Wagner-Johnston ND; Vose JM; Fenske TS
Cancer; 2014 Jul; 120(14):2122-9. PubMed ID: 24711253
[TBL] [Abstract][Full Text] [Related]
8. Hodgkin lymphoma patients in first remission: routine positron emission tomography/computerized tomography imaging is not superior to clinical follow-up for patients with no residual mass.
Dann EJ; Berkahn L; Mashiach T; Frumer M; Agur A; McDiarmid B; Bar-Shalom R; Paltiel O; Goldschmidt N
Br J Haematol; 2014 Mar; 164(5):694-700. PubMed ID: 24313286
[TBL] [Abstract][Full Text] [Related]
9. Value of surveillance computed tomography in the follow-up of diffuse large B-cell and follicular lymphomas.
Lin TL; Kuo MC; Shih LY; Dunn P; Wang PN; Wu JH; Tang TC; Chang H; Hung YS; Lu SC
Ann Hematol; 2012 Nov; 91(11):1741-5. PubMed ID: 22729139
[TBL] [Abstract][Full Text] [Related]
10. Positron emission tomography/computed tomography surveillance in patients with Hodgkin lymphoma in first remission has a low positive predictive value and high costs.
El-Galaly TC; Mylam KJ; Brown P; Specht L; Christiansen I; Munksgaard L; Johnsen HE; Loft A; Bukh A; Iyer V; Nielsen AL; Hutchings M
Haematologica; 2012 Jun; 97(6):931-6. PubMed ID: 22207683
[TBL] [Abstract][Full Text] [Related]
11. Effect of Routine Surveillance Imaging on the Outcomes of Patients With Classical Hodgkin Lymphoma After Autologous Hematopoietic Cell Transplantation.
Kapke JT; Epperla N; Shah N; Richardson K; Carrum G; Hari PN; Pingali SR; Hamadani M; Karmali R; Fenske TS
Clin Lymphoma Myeloma Leuk; 2017 Jul; 17(7):408-414. PubMed ID: 28756899
[TBL] [Abstract][Full Text] [Related]
12. Positron emission tomography with [18F]2-fluoro-D-2-deoxyglucose (FDG-PET) predicts relapse of malignant lymphoma after high-dose therapy with stem cell transplantation.
Becherer A; Mitterbauer M; Jaeger U; Kalhs P; Greinix HT; Karanikas G; Pötzi C; Raderer M; Dudczak R; Kletter K
Leukemia; 2002 Feb; 16(2):260-7. PubMed ID: 11840293
[TBL] [Abstract][Full Text] [Related]
13. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
Hagemeister FB
Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
[TBL] [Abstract][Full Text] [Related]
14. Surveillance imaging during remission identifies a group of patients with more favorable aggressive NHL at time of relapse: a retrospective analysis of a uniformly-treated patient population.
Liedtke M; Hamlin PA; Moskowitz CH; Zelenetz AD
Ann Oncol; 2006 Jun; 17(6):909-13. PubMed ID: 16672295
[TBL] [Abstract][Full Text] [Related]
15. Surveillance computed tomography imaging and detection of relapse in intermediate- and advanced-stage pediatric Hodgkin's lymphoma: a report from the Children's Oncology Group.
Voss SD; Chen L; Constine LS; Chauvenet A; Fitzgerald TJ; Kaste SC; Slovis T; Schwartz CL
J Clin Oncol; 2012 Jul; 30(21):2635-40. PubMed ID: 22689804
[TBL] [Abstract][Full Text] [Related]
16. Relapse after treatment of pediatric Hodgkin lymphoma: outcome and role of surveillance after end of therapy.
Friedmann AM; Wolfson JA; Hudson MM; Weinstein HJ; Link MP; Billett A; Larsen EC; Yock T; Donaldson SS; Marcus K; Krasin MJ; Howard SC; Metzger ML
Pediatr Blood Cancer; 2013 Sep; 60(9):1458-63. PubMed ID: 23677874
[TBL] [Abstract][Full Text] [Related]
17. Optimal disease surveillance strategies in non-Hodgkin lymphoma.
Cohen JB; Flowers CR
Hematology Am Soc Hematol Educ Program; 2014 Dec; 2014(1):481-7. PubMed ID: 25696898
[TBL] [Abstract][Full Text] [Related]
18. Evaluating surveillance imaging for diffuse large B-cell lymphoma and Hodgkin lymphoma.
Cohen JB; Behera M; Thompson CA; Flowers CR
Blood; 2017 Feb; 129(5):561-564. PubMed ID: 27956385
[TBL] [Abstract][Full Text] [Related]
19. Utility of Routine Surveillance Laboratory Testing in Detecting Relapse in Patients With Classic Hodgkin Lymphoma in First Remission: Results From a Large Single-Institution Study.
Lynch RC; Sundaram V; Desai M; Henry S; Wood D; Daadi S; Hoppe RT; Advani R
JCO Oncol Pract; 2020 Sep; 16(9):e902-e911. PubMed ID: 32369413
[TBL] [Abstract][Full Text] [Related]
20. [Analysis of prognostic factors in children with B-cell non-Hodgkin lymphoma (B-NHL)].
Zajac-Spychała O; Derwich K; Mańkowska M; Konatkowska B; Mańkowski P; Wachowiak J
Med Wieku Rozwoj; 2008; 12(4 Pt 2):1087-91. PubMed ID: 19531831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
